Summary:The role of prostaglandins in maintenance of resting cerebral blood flow (CBF) and in cerebral vaso dilatation during hypercapnia remains controversial. The effect of indomethacin, a cyclo-oxygenase inhibitor, on CBF and cerebrovascular resistance (CVR) was exam ined in conscious animals. Regional and total CBF were measured with radioactive microspheres, and the efficacy of blockade of prostaglandin synthesis by indomethacin was examined by the cranial window method. CBF was measured in conscious rabbits with 15-lLm radioactive mi crospheres during normocapnia (Peo2 = 30 mm Hg) and hypercapnia (Peo2 = 60 mm Hg), before and after intra venous administration of indomethacin (10 mg/kg) or ve hicle (n = 6 for each). Thus, each animal served as its own control. CBF was 84 ± 6 and 190 ± 27 (mean ± SE) mllmin/lOO g during normocapnia and hypercapnia, respectively, before indomethacin, and 78 ± 5 mllmin/l00 g during normocapnia and 180 ± 16 mllmin/lOO g during hypercapnia following indomethacin. Thus, indomethacin Although prostaglandins are synthesized by ce rebral vessels and brain parenchyma (Wolfe et al., 1976;Abdel-Halim et al., 1980; Goehlert et aI., 1981) and exert vasoactive effects (Ellis et aI., 1979), their role in regulation of cerebral blood flow (CBF) is unclear. The role of prostaglandins in the control of CBF has been examined primarily by the use of cyclo-oxygenase inhibitors such as indomethacin. Several investigators have found that indomethacin decreases CBF during normocapnia by 30-50% and virtually eliminates the increase in CBF during hy percapnia in anesthetized monkeys, rats, gerbils, and conscious rats (Pickard and Mackenzie, 1973;Sakabe and Siesj6, 1979; Dahlgren et al., 1981a,b;
376did not change normocapnic CBF. In addition, cerebro vascular responses during hypercapnia did not vary be tween the indomethacin and vehicle groups. Indometh acin did not attenuate increases in blood flow in any area of the brain, except slightly to cerebellum during hyper capnia. Indomethacin did not affect CVR during normo capnia or hypercapnia. The topical application of arachi donic acid (75 and 150 lLg/mg), dissolved in cerebrospinal fluid, dilated pial arteries in a dose-dependent fashion. Intravenous administration of indomethacin (10 mg/kg) blocked vasodilatation produced by arachidonic acid by 87% (p < 0.05). Thus, indomethacin, at a dose that ef fectively inhibits prostaglandin synthesis, did not change resting CBF or CVR or attenuate the increase in CBF or decrease in CVR during hypercapnia. These findings sug gest that prostaglandins do not contribute significantly to regulation of the cerebral circulation during normocapnia and hypercapnia.